tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

PainReform completes strategic investment in LayerBio

PainReform (PRFX) announced, through its pharmaceutical division, the closing of its previously announced investment in LayerBio. With this transaction, PainReform has acquired a majority equity interest in LayerBio and plans to initiate the next clinical trial of OcuRing-K, LayerBio’s lead investigational product for pain and inflammation control following cataract surgery.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1